electroCore, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
electroCore, Inc. (ECOR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 98 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-03-12
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was -97.90K shares.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 203.00K shares, a 83.59% decline year-over-year.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 98.00 shares, a 99.95% decline from fiscal 2023.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 206.00K shares, a 196090.48% increase from fiscal 2022.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 105.00 shares, a 99.99% decline from fiscal 2021.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 1.36M shares, a 32.89% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | -97.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 98.00 shares 10-K · filed 2025-03-12 | |||
| 2024-09-30 | 98.00K shares 10-Q · filed 2024-11-13 | ||||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 203.00K shares derived: sum of 2 quarters · filed 2024-03-13 | 203.00K shares derived: sum of 3 quarters · filed 2024-03-13 | 206.00K shares 10-K · filed 2024-03-13 | |
| 2023-09-30 | 203.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 203.00K shares derived: sum of 2 quarters · filed 2023-11-08 | 206.00K shares 10-Q · filed 2023-11-08 | -1.03M shares derived: sum of 4 quarters · filed 2023-11-08 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 3.00K shares 10-Q · filed 2023-08-09 | -1.23M shares derived: sum of 3 quarters · filed 2023-08-09 | 1.87K shares derived: sum of 4 quarters · filed 2023-08-09 | |
| 2023-03-31 | 3.00K shares 10-Q · filed 2023-05-03 | -1.23M shares derived: sum of 2 quarters · filed 2023-05-03 | 1.87K shares derived: sum of 3 quarters · filed 2023-05-03 | 1.92K shares derived: sum of 4 quarters · filed 2023-05-03 | |
| 2022-12-31 | -1.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -1.13K shares derived: sum of 2 quarters · filed 2023-03-08 | -1.08K shares derived: sum of 3 quarters · filed 2023-03-08 | 105.00 shares 10-K · filed 2023-03-08 | |
| 2022-09-30 | 1.24M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 1.24M shares derived: sum of 2 quarters · filed 2022-11-03 | 1.24M shares 10-Q · filed 2022-11-03 | 1.25M shares derived: sum of 4 quarters · filed 2022-11-03 | |
| 2022-06-30 | 51.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.24K shares 10-Q · filed 2022-08-04 | 11.24K shares derived: sum of 3 quarters · filed 2022-08-04 | 81.24K shares derived: sum of 4 quarters · filed 2022-08-04 | |
| 2022-03-31 | 1.19K shares 10-Q · filed 2022-05-05 | 11.19K shares derived: sum of 2 quarters · filed 2022-05-05 | 81.19K shares derived: sum of 3 quarters · filed 2022-05-05 | 266.32K shares derived: sum of 4 quarters · filed 2022-05-05 | |
| 2021-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 80.00K shares derived: sum of 2 quarters · filed 2022-03-10 | 265.14K shares derived: sum of 3 quarters · filed 2022-03-10 | 1.36M shares 10-K · filed 2022-03-10 | |
| 2021-09-30 | 70.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 255.14K shares derived: sum of 2 quarters · filed 2021-11-04 | 1.35M shares 10-Q · filed 2021-11-04 | 1.52M shares derived: sum of 4 quarters · filed 2021-11-04 | |
| 2021-06-30 | 185.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 1.28M shares 10-Q · filed 2021-08-05 | 1.45M shares derived: sum of 3 quarters · filed 2021-08-05 | 1.45M shares derived: sum of 4 quarters · filed 2021-08-05 | |
| 2021-03-31 | 1.09M shares 10-Q · filed 2021-05-06 | 1.26M shares derived: sum of 2 quarters · filed 2021-05-06 | 1.26M shares derived: sum of 3 quarters · filed 2021-05-06 | 2.25M shares derived: sum of 4 quarters · filed 2021-05-06 | |
| 2020-12-31 | 175.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 175.00K shares derived: sum of 2 quarters · filed 2021-03-11 | 1.16M shares derived: sum of 3 quarters · filed 2021-03-11 | 2.02M shares 10-K · filed 2021-03-11 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 983.04K shares derived: sum of 2 quarters · filed 2020-11-12 | 1.84M shares 10-Q · filed 2020-11-12 | 2.67M shares derived: sum of 4 quarters · filed 2020-11-12 | |
| 2020-06-30 | 983.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 1.84M shares 10-Q · filed 2020-08-13 | 2.67M shares derived: sum of 3 quarters · filed 2020-08-13 | 2.67M shares derived: sum of 4 quarters · filed 2020-08-13 | |
| 2020-03-31 | 861.26K shares 10-Q · filed 2020-05-15 | 1.68M shares derived: sum of 2 quarters · filed 2020-05-15 | 1.69M shares derived: sum of 3 quarters · filed 2020-05-15 | 2.22M shares derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-12-31 | 821.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 829.32K shares derived: sum of 2 quarters · filed 2020-03-30 | 1.36M shares derived: sum of 3 quarters · filed 2020-03-30 | 2.15M shares 10-K · filed 2020-03-30 | |
| 2019-09-30 | 7.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 541.00K shares derived: sum of 2 quarters · filed 2019-11-14 | 1.33M shares 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | 533.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 1.32M shares 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | 784.17K shares 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | 104.37K shares 10-K · filed 2019-03-28 | ||||
| 2018-06-21 | 2.14M shares 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |